Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Shares IssuedShares OutstandingShares OutstandingShort-Term Debt issuances
Ratios

P3 Health Partners (PIIIW) Shares Issued (2021 - 2024)

P3 Health Partners posted quarterly Shares Issued of -$51000.0 for Q4 2024, up 92.14% year-on-year from -$26542.9 in Q1 2024, and up 96.98% on a QoQ basis from -$1.7 million in Q3 2024.

P3 Health Partners (PIIIW) has 3 years of Shares Issued data on file, last reported at -$51000.0 in Q4 2024.

  • For the quarter ending Q4 2024, Shares Issued rose 92.14% year-over-year to -$51000.0; the trailing twelve-month figure through Dec 2025 stood at -$1.7 million (up 29.69% YoY), and the FY2024 full-year result was $40.5 million, down 53.24% from the prior year.
  • Shares Issued for Q4 2024 stood at -$51000.0, up from -$1.7 million in the prior quarter.
  • Across five years, Shares Issued topped out at $309.9 million in Q1 2021 and bottomed at -$301.6 million in Q2 2021.
  • The 3-year median for Shares Issued is -$85000.0 (2023), against an average of $43.9 million.
  • Peak annual rise in Shares Issued reached 92.14% in 2024, while the deepest fall reached 1884.71% in 2024.
  • A 3-year view of Shares Issued shows it stood at $301.6 million in 2021, then sank by 100.22% to -$649000.0 in 2023, then surged by 92.14% to -$51000.0 in 2024.
  • The last three Shares Issued figures came in at -$51000.0 (Q4 2024), -$1.7 million (Q3 2024), and -$649000.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Issued (Qtr)
1 HCA Healthcare 84.64 Bn 87.02 Bn 16.26 Bn -
2 Tenet Healthcare 15.22 Bn 14.39 Bn 4.41 Bn -
3 Davita 13.10 Bn 13.96 Bn 1.07 Bn 2.39 Mn
4 Encompass Health 10.50 Bn 11.12 Bn 1.34 Bn -
5 Ensign 9.69 Bn 9.09 Bn 293.37 Mn 11.49 Mn
6 Universal Health Services 8.92 Bn 8.88 Bn 3.21 Bn 3.78 Mn
7 Fresenius Medical Care AG 7.31 Bn 4.93 Bn 22,843.10 Bn -
8 Chemed 5.83 Bn 5.81 Bn 215.76 Mn 1.31 Mn
9 Pacs 5.76 Bn 5.51 Bn 345.96 Mn -
10 P3 Health Partners - - 384.48 Mn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2024 -51,000.00
Dec 31, 2024 -51,000.00
Sep 30, 2024 -1.69 Mn
Sep 30, 2024 -1.69 Mn
Dec 31, 2023 -649,000.00
Dec 31, 2023 -649,000.00
Sep 30, 2023 -85,000.00
Sep 30, 2023 -85,000.00
Sep 30, 2021 301.60 Mn
Sep 30, 2021 301.60 Mn
Jun 30, 2021 -301.60 Mn
Jun 30, 2021 -301.60 Mn
Mar 31, 2021 309.92 Mn
Mar 31, 2021 309.92 Mn